Your browser doesn't support javascript.
loading
Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium.
Chu, Xiaoyan; Liao, Mingxiang; Shen, Hong; Yoshida, Kenta; Zur, Arik A; Arya, Vikram; Galetin, Aleksandra; Giacomini, Kathleen M; Hanna, Imad; Kusuhara, Hiroyuki; Lai, Yurong; Rodrigues, David; Sugiyama, Yuichi; Zamek-Gliszczynski, Maciej J; Zhang, Lei.
Afiliación
  • Chu X; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc, Kenilworth, New Jersey, USA.
  • Liao M; Department of Clinical Pharmacology, Clovis Oncology, Inc., Boulder, Colorado, USA.
  • Shen H; Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb, Princeton, New Jersey, USA.
  • Yoshida K; Clinical Pharmacology, Genentech Research and Early Development, South San Francisco, California, USA.
  • Zur AA; BiolineRX, Modi'in, Israel.
  • Arya V; Division of Clinical Pharmacology IV, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Galetin A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK.
  • Giacomini KM; Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco, California, USA.
  • Hanna I; Pharmacokinetic Sciences, Novartis Institutes for Biomedical Research, East Hanover, New Jersey, USA.
  • Kusuhara H; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Lai Y; Drug Metabolism, Gilead Science, Inc., Foster City, California, USA.
  • Rodrigues D; Pharmacokinetics, Dynamics, & Metabolism, Medicine Design, Pfizer Inc., Groton, Connecticut, USA.
  • Sugiyama Y; Sugiyama Laboratory, RIKEN Baton Zone Program, Cluster for Science, RIKEN, Yokohama, Japan.
  • Zamek-Gliszczynski MJ; Quantitative Drug Disposition, GlaxoSmithKline PLC, King of Prussia, Pennsylvania, USA.
  • Zhang L; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Clin Pharmacol Ther ; 104(5): 836-864, 2018 11.
Article en En | MEDLINE | ID: mdl-30347454
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Transporte de Membrana / Farmacocinética / Biomarcadores / Sondas Moleculares / Interacciones Farmacológicas / Moduladores del Transporte de Membrana / Desarrollo de Medicamentos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Transporte de Membrana / Farmacocinética / Biomarcadores / Sondas Moleculares / Interacciones Farmacológicas / Moduladores del Transporte de Membrana / Desarrollo de Medicamentos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos